Despite several tumors exhibit upregulated LIF/LIFR-STAT3 signaling via autocrine and paracrine mechanisms, the mechanistic relevance of this pathway and its therapeutic potential in GC remains elusive. The gene discussed is LIF; the disease is gastric cancer.